Recent Posts
- Inflation Reduction Act Will Mean Big Price Increases On Prescription Drugs
- Federal PBM Probe Culminates Decades of M&A
- Insurers Slam Critical Drug-Pricing Research But Can’t Vouch For Their Own
- ‘For good rather than evil’: Mark Cuban and an employer’s coalition to launch new PBMs to lower drug costs
- Kansas audited its $80 million CVS prescription plan, but it’s still shrouded in mystery